Daptomycin use in neutropenic patients with documented gram-positive infections

Whole-Genome Analysis of a Daptomycin-Susceptible Enterococcus faecium Strain and Its Daptomycin-Resistant Variant Arising during Therapy

(2012) Truc T. Tran et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Patients with Cancer Treated with Vancomycin: 9-Year Experience at a Comprehensive Cancer Center

(2012) S. N. Mahajan et al.   ONCOLOGIST

Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial

(2011) John A. Bosso et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients

(2010) Anne-Marie Chaftari et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization

(2010) V. E. Mulanovich et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

(2010) Shawna Kraft et al.   SUPPORTIVE CARE IN CANCER

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin Pharmacokinetics in Adult Oncology Patients with Neutropenic Fever

(2008) J. S. Bubalo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

265: Daptomycin Plus Cefepime for Moderate and High-Risk Febrile Neutropenic Patients with Increased Risk of Gram-Positive Infection

(2008) J.M. Rossetti et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia

(2007) K. M. Erlandson et al.   CLINICAL INFECTIOUS DISEASES

Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

(2007) Matthew E Falagas et al.   LANCET INFECTIOUS DISEASES